In pediatric bradycardia, what should be done if there is no response to epinephrine?
Select Your Answer:
In pediatric bradycardia, atropine should be administered if no response to epinephrine and only if vagal or cholinergic drug toxicity cause. Hypoxemia is the number one cause of bradycardia in the pediatric population. NOTE: Oxygenate and ventilate, if this fails give Epinephrine IV in a poorly perfusing patient.
Atropine may be repeated only once in pediatric bradycardia. Atropine dose is 0.02 mg/kg IV or IO, minimum dose of 0.1 mg and max single dose of 0.5 mg. Poor perfusion requires emergency intervention. Cap refill of over 2 seconds, hypotension, faint pulses, altered level of consciousness and cool skin can signify poor perfusion that requires life saving interventions.
Epinephrine 0.01mg/kg (1:10,000) or 0.1 ml/kg may be administered every 3 to 5 minutes IV or IO. External pacing can be considered. Transcutaneous pacing is painful and sedation should be considered. Adult size pacer pads are used if over 10 kg. Demand rate setting starts at 100 and MA is adjusted until capture. A pediatric resuscitation tape will be useful.
Remember to provide oxygen and ventilate, if heart rate less than 60 with poor perfusion then chest compressions should be initiated. Pediatric bradycardia is defined as a heart rate of less than a child's normal heart rate according to their age unless a highly trained athlete.
Outcomes Associated With Electrical Cardioversion for Atrial Fibrillation When Performed Autonomously by an Advanced Practice Provider., Strzelczyk TA,Kaplan RM,Medler M,Knight BP,, JACC. Clinical electrophysiology, 2017 Dec 11 [PubMed]
Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction., Hirschy R,Ackerbauer KA,Peksa GD,O'Donnell EP,DeMott JM,, The American journal of emergency medicine, 2018 Apr 27 [PubMed]
Imaging characteristics and pathogenesis of intracranial artery stenosis in patients with acute cerebral infarction., Xu W,Xie N,Zhang C,Huang Q,, Experimental and therapeutic medicine, 2018 May [PubMed]